Ai vu Hong, Research Fellow, and Laura Palmieri, PhD student, both members of Généthon’s progressive muscular dystrophies team, led by Isabelle Richard, received awards at the ASGCT 2023 congress held in Los Angeles from May 16 to 20.
Ai Vu Hong received two awards: one for Excellence in Research, which rewards the 10 to 15 best abstracts submitted by researchers, and the other, a Meritorious Abstract Travel Award, given An integrin-targeting AAV developed by a novel computational rational design methodology presents an improved targeting to the skeletal muscle and reduced tropism to the liver
“As always, the ASGCT has highlighted many advances and innovations in cell and gene therapies this year,” said Ai Vu Hong. “I am extremely grateful and honored to have received 2 awards. This recognition from the ASGCT organizers underscores the efforts our group has devoted to optimizing AAV-vectored gene therapy for neuromuscular diseases and making it safer. I am more motivated than ever to continue our work and our mission”.
For her part, Laura Palmieri also won a Meritorious Abstract Travel Award, which highlights the importance of her work in helping to advance the field of gene and cell therapy: Development of MYOrganoids for therapeutic evaluation of gene therapy product in Duchenne Muscular Dystrophy
Congratulations to both of you!